Literature DB >> 35112330

An update on microneedle-based systems for diabetes.

Wen Xuan Li1, Xiao Peng Zhang1, Bo Zhi Chen1, Wen Min Fei2,3, Yong Cui4,5, Can Yang Zhang6, Xin Dong Guo7.   

Abstract

Diabetes is one of the most serious chronic diseases today. Patients with diabetes need frequent insulin injections or blood sampling to monitor blood glucose levels. The microneedles are a painless transdermal drug delivery system, which has great advantages in achieving self-management. There have been a lot of researches on microneedles used in diabetes treatment. Microneedle-based treatment of diabetes has also changed from a simple and reliable system to a complex and efficient system. This review introduces microfluidic, glucose response, and other contents based on microneedles, and some challenges in the development of microneedles.
© 2022. Controlled Release Society.

Entities:  

Keywords:  Diabetes; Integrated system; Microfluidic; Microneedles

Mesh:

Substances:

Year:  2022        PMID: 35112330     DOI: 10.1007/s13346-021-01113-2

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   5.671


  43 in total

Review 1.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs.

Authors:  J D Bos; M M Meinardi
Journal:  Exp Dermatol       Date:  2000-06       Impact factor: 3.960

2.  Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.

Authors:  Yu-Hung Chen; Kuan-Ying Lai; Yu-Hsiu Chiu; Yan-Wei Wu; Ai-Li Shiau; Mei-Chin Chen
Journal:  Acta Biomater       Date:  2019-07-27       Impact factor: 8.947

Review 3.  Therapeutic applications and pharmacoeconomics of microneedle technology.

Authors:  Jolanda Richter-Johnson; Pradeep Kumar; Yahya E Choonara; Lisa C du Toit; Viness Pillay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-06-14       Impact factor: 2.217

Review 4.  Transdermal drug delivery by passive diffusion and iontophoresis: a review.

Authors:  S Singh; J Singh
Journal:  Med Res Rev       Date:  1993-09       Impact factor: 12.944

Review 5.  The history of insulin.

Authors:  M Bliss
Journal:  Diabetes Care       Date:  1993-12       Impact factor: 19.112

6.  Combined Silk Fibroin Microneedles for Insulin Delivery.

Authors:  Mingmei Zhu; Yang Liu; Fujian Jiang; Jiaxin Cao; Subhas C Kundu; Shenzhou Lu
Journal:  ACS Biomater Sci Eng       Date:  2020-05-04

7.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

Review 8.  Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.

Authors:  Ryan F Donnelly; Thakur Raghu Raj Singh; A David Woolfson
Journal:  Drug Deliv       Date:  2010-05       Impact factor: 6.419

9.  Dissolving microneedle with high molecular weight hyaluronic acid to improve skin wrinkles, dermal density and elasticity.

Authors:  M Jang; S Baek; G Kang; H Yang; S Kim; H Jung
Journal:  Int J Cosmet Sci       Date:  2020-06       Impact factor: 2.970

10.  Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules.

Authors:  Lalitkumar K Vora; Aaron J Courtenay; Ismaiel A Tekko; Eneko Larrañeta; Ryan F Donnelly
Journal:  Int J Biol Macromol       Date:  2019-12-26       Impact factor: 6.953

View more
  2 in total

1.  Simvastatin Loaded Dissolvable Microneedle Patches with Improved Pharmacokinetic Performance.

Authors:  Nadiah Zafar; Asif Mahmood; Rai Muhammad Sarfraz; Abdelhamid Elaissari
Journal:  Micromachines (Basel)       Date:  2022-08-12       Impact factor: 3.523

Review 2.  The most promising microneedle device: present and future of hyaluronic acid microneedle patch.

Authors:  Huizhi Kang; Zhuo Zuo; Ru Lin; Muzi Yao; Yang Han; Jing Han
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.